KIDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OrthoPediatrics Corp (KIDS) is not a strong buy at the moment for a beginner investor with a long-term horizon. The technical indicators show bearish trends, the options data suggests a lack of bullish sentiment, and the company's financial performance reflects declining profitability despite revenue growth. While analysts are optimistic with raised price targets and buy ratings, the lack of recent positive news or significant catalysts, coupled with weak technical signals, suggests holding off on purchasing this stock right now.
The MACD is below 0 and negatively contracting, RSI is neutral at 37.188, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 15.948 and resistance at 17.659. Overall, the technical indicators suggest a bearish trend.
Analysts have raised price targets and maintain buy ratings, citing the company's leadership in pediatric orthopedics and potential for sustained revenue growth. Hedge funds have increased their buying activity significantly.
No recent news or event-driven catalysts. Insiders are neutral, and there is no recent congressional trading data. The stock's technical indicators and options data reflect bearish sentiment.
In Q4 2025, revenue increased by 16.97% YoY to $61.61M, and gross margin improved to 73.22%. However, net income dropped by 37.13% YoY to -$10.1M, and EPS decreased by 37.68% to -0.43, indicating declining profitability.
Analysts are optimistic, with multiple raised price targets (ranging from $20 to $24) and buy ratings. They highlight the company's leadership in its niche market and potential for profitability improvements, though current valuations may not fully reflect these prospects.
